TV Personality Einat Erlich Reveals Brain Cancer Diagnosis
Translated & summarized from N12 by baba
Israeli TV personality Einat Erlich revealed she was diagnosed with glioblastoma, an aggressive brain cancer, this week. She has already undergone successful surgery to remove the tumor and is beginning further treatment, expressing determination to win her battle.
The story in 4 lines · by baba
- TV personality Einat Erlich diagnosed with aggressive brain cancer.
- She underwent successful surgery to remove the tumor.
- Erlich is beginning further treatment for glioblastoma.
- She expressed strength and determination to overcome the illness.
Israeli television personality Einat Erlich announced on Thursday that she has been diagnosed with glioblastoma, an aggressive malignant brain tumor. In a personal post shared on her Instagram account, Erlich revealed that she received the diagnosis this week, stating, "I am no longer healthy. This week I was diagnosed with GBM, glioblastoma. Brain cancer. Words I never thought I would write about myself."
She further disclosed that she underwent a complex and successful surgery last week to remove the tumor, performed by doctors at Ichilov Hospital. Erlich acknowledged the fear and uncertainty accompanying the diagnosis, admitting to feeling fear, anger, and sadness. However, she emphasized the overwhelming love and support she has received from her family, friends, and partner, Johnny.
Looking ahead, Erlich stated she is beginning the next phase of treatment and expressed determination to overcome the illness. "I am starting a journey to healing now. I will use everything I have learned over the years about listening to the body and the power of a person. And I have strength. A lot of strength. I am strong. I am well. I am on my feet. And I will win. There is no other option!" she wrote.
Glioblastoma (GBM) is a primary malignant and aggressive brain tumor. Standard treatment typically involves surgery to remove as much of the tumor as possible, followed by radiation and medication. New treatments are also being explored in clinical trials.
